Introduction
Arterial blood gas (ABG) analysis is integral to the assessment of critical illness, providing information on both the aetiology and severity of a disease process. Barcroft [1] and Henderson [2] developed experimental and mathematical methods of assessing ventilation and acid-base states in the first two decades of the 20th century. This knowledge was applied medically by 1920 [3] . Initially information was provided on ventilation [partial pressure of oxygen (PO 2 ) and partial pressure of carbon dioxide (PCO 2 )] and acid-base balance [pH, bicarbonate (HCO 3 -) and base excess]. However, more recent analysers also measure glucose, electrolytes, renal function, bilirubin and haemoglobin, providing a metabolic profile. Point-of-care emergency department (ED)-based analysers provide this information very rapidly, enabling the clinician to identify and correct life-threatening abnormalities in real time.
However, arterial puncture carries risks, including arterial injury and thrombosis [4] . It is a painful procedure that can be challenging to perform. Consequently, venous blood gas (VBG) analysis is becoming an increasingly popular alternative. VBG is also associated with reduced pain and time for collection, as most patients will require venipuncture as part of their acute assessment.
The relationship between the numerical values obtained from VBG and ABG have been investigated for more than half a century [5] . The objective of this study is to provide a systematic review of the literature reporting agreement between arterial and venous pH, PCO 2 , bicarbonate, base excess and lactate; and to perform a meta-analysis of the differences.
Methods

Population of interest
Inclusion criteria were articles reporting comparisons of venous and arterial blood taken from adult patients in the ED. Children, central or mixed venous blood samples, ICU or medical in-patients were excluded.
Literature search
Medline and Embase searches using Eduserv Athens from 1950 to present were conducted using the terms 'VBG', 'ABG', 'arterial', 'venous', 'blood', 'gas', 'lactate', 'emergency' and 'department'. The search was conducted in June 2009 and repeated in September 2012. Titles and abstracts were reviewed to identify papers that could contribute to the question, and full-text versions were acquired. In addition, references of the published papers were hand searched and full-text versions of those deemed pertinent were obtained.
Data extraction and analysis
Agreement statistics including mean difference (MD) between venous and arterial values and 95% limits of agreement (LOA) are reported, as described by Bland and Altman [6] . However, the published evidence varies in its representation of agreement. Variation in reporting the difference between ABG and VBG values includes reporting MD alone, MD and SD, LOA alone, mean arterial and mean venous values with confidence intervals (CIs) but no agreement statistics, correlation and graphical form only. Where directly quoted, MDs and LOA have been transferred into tables. In cases in which the MD is quoted with SD, the LOA have been calculated by the authors. In cases in which LOA alone are quoted, MD and SD have been calculated by the authors. In cases in which only graphical representations of the agreement are published, the MD, SD and LOA have been calculated by ascertaining the values of each point on the graph using the computer application PlotDigitizer (freeware by J.A. Huwalt). In one article, MD with CIs was reported [7] . In this case, SD was calculated using the method specified in Cochrane Handbook for Systematic Reviews of Interventions, and LOA were derived from the calculated SD as MD±2 SD [8] . In this study, for the purposes of standardization, where differences are originally reported as arterial minus venous, the authors have converted these to venous minus arterial. The data extraction and analysis were thus far performed by B.M.B.
For the purposes of pooling the MDs, 95% CIs are required. In cases in which 95% CIs are not reported in the source text, they were calculated from the reported MD. CIs for a mean are a function of the SEM, which is the SD divided by the square root of the population sample. LOA are the range of the mean plus or minus the SD multiplied by 2. Therefore CIs are necessarily narrower than LOA.
The data were then combined and pooled MDs were calculated. The Higgins I 2 -test for heterogeneity was applied. When comparing pH, PCO 2 and bicarbonate, a random effects meta-analysis was performed as there was a statistically significant heterogeneity [9] . When comparing lactate, no heterogeneity was found, so a fixed effects metaanalysis was used. The meta-analysis was performed by J.P.B.
Results
Ninety-three potentially relevant articles were identified of which 13, 12, 10 and three met the inclusion criteria for pH, PCO 2 , bicarbonate and lactate, respectively. These are displayed in Table 1 .
The pooled MD for pH was -0.033 pH units (95% CI -0.039 to -0.027) with widest individually reported 95% LOA -0.13 to 0.10 pH units [18] , for PCO 2 was 4.41 mmHg (95% CI 2.55-6.27) with widest individually reported 95% LOA -20.40 to 25.80 mmHg [15] , for bicarbonate was 1.03 mmol/l (95% CI 0.56-1.50) with widest individually reported 95% LOA -6.24 to 10.00 mmol/l [19] and the pooled MD for lactate was 0.25 mmol/l (95% CI 0.15-0.35) with the widest individually reported 95% LOA 1.95-2.31 mmol/l (Figs 1-4) [27] .
Discussion
It is important to note that the MD is a point-estimation and therefore carries a CI. The LOA are not the same as the CI: the LOA is a range in which any individual arterial minus venous difference may lie, whereas the CI is a range in which the average or MD may lie. CIs are necessarily narrower than LOA for reasons described above, and are not as clinically relevant in this situation. It is the 95% LOA that are important for the physician to use to understand the true potential spread of difference from the value he or she may acquire from any one venous sample and the corresponding potential arterial value.
pH and bicarbonate
In the 13 studies examining pH, six studies [7, 10, 12, 15, 18, 19] compared peripheral venous and peripheral arterial pH values in an ED convenience sample. Four studies compared samples in patients with chronic obstructive pulmonary disease (COPD) and other respiratory conditions [13] [14] [15] 19] ; three report on patients with diabetic ketoacidosis [11, 17, 21] , although one also reports a separate group of patients with uraemia [13] and one reports on the differences in pH in patients who have taken tricyclic antidepressant overdose [20] . Of those 12 studies eight of them also examine bicarbonate and there is one study examining bicarbonate that does not report pH [28] .
Shirani et al. [15] specifically compared the differences between a normotensive group and an all-cause hypotensive group [defined as a systolic blood pressure (SBP) less than 90 mmHg] in a convenience sample of ED patients. They found the MD in the normotensive group to be -0.016 pH units (95% LOA -0.10 to 0.07) and in the hypotensive group to be -0.030 pH units (95% LOA -0.09 to 0.03). They found poorer agreement in bicarbonate, with MD 1.32 mmol/l (95% LOA -1.94 to 4.58) and MD 1.79 mmol/l (95% LOA -1.91 to 5.49) in the normotensive and hypotensive groups, respectively. The remaining studies include limited data from hypotensive patients. Gennis et al. [12] stated that eight of 188 patients had an SBP of less than 100 mmHg and Malatesha et al. [18] stated that three of 95 patients had an SBP less than 90 mmHg.
The lowest 95% LOA for bicarbonate was 0.88 to 2.56 mmol/l [17] , which was reported in a group of uraemic patients. This could be considered narrow enough to be clinically useful. However, many studies report much broader LOA. Razi and Moosavi [16] reported the broadest 95% LOA for bicarbonate at -6.24 to 10.00 mmol/l. This may be because they investigated a patient population whose main inclusion criterion was hypercapnic respiratory failure. For those patients who have chronic type II respiratory failure, the bicarbonate is likely to be higher than the upper limit of normal. This taken with an overlying respiratory acidosis may confer a higher chance of poor agreement between arterial and venous bicarbonate. Clearly LOA as broad as this are too wide to be clinically acceptable.
No study concentrated on acidotic patients, although Kelly et al. [10] reported that 67 out of 246 patients were acidotic and Ma et al. [11] reported that 48 out of 195 were acidotic. Others report ranges that include acidotic The role of venous blood gas in the ED Bloom et al. 83
patients. The lack of evidence specifically examining mixed acid-base disorders means that in this important subgroup replacement of arterial with venous parameters cannot be advocated.
In a previous meta-analysis, Kelly [29] reported a pooled MD of 0.035 pH units for pH and 1.41 mmol/l for bicarbonate. Lim and Kelly [30] performed a metaanalysis limiting the subject population to patients with exacerbations of COPD. In that study, the pooled MDs were 0.028 pH units and 1.34 mmol/l for pH and bicarbonate, respectively. LOA were not pooled but reported as stated in the source literature.
Our meta-analysis found that the pooled MD for pH was -0.033 pH units (95% CI -0.039 to -0.027) and that for bicarbonate was 1.03 mmol/l (95% CI 0.56-1.50). Both our and the previously reported meta-analyses found that venous and arterial pH values agree closely enough to be used interchangeably in patients that are not shocked or with a mixed respiratory and metabolic acid-base disorder. However, there is no sufficient evidence to advocate replacement of arterial with venous sampling in patients with hypotension.
PCO 2
Twelve studies compared arterial and venous PCO 2 , of which four studies compared arterial and venous PCO 2 in ED convenience samples [7, 15, 18, 23] , five investigated patients with respiratory disease (four COPD and one acute respiratory illness) [14, 16, 19, 22, 24] and one investigated patients who had taken a tricyclic antidepressant overdose [20] . In all studies, agreement is poor, with MD ranging from -5.3 to 8.6 mmHg and LOA ranging to ±20 mmHg.
There are two previously published meta-analyses examining PCO 2 . Kelly [29] reported an MD of 5.7 mmHg. Lim and Kelly [30] analysed studies consisting only of patients with COPD and reported an MD of 5.92 mmHg.
In our meta-analysis, we calculated the pooled MD to be 4.41 mmHg (95% CI 2.55-6.27), which is substantially narrower than that reported in the two previous metaanalyses. We report broad CIs, which may explain the discrepancy between our findings and previous results. In addition, the meta-analysis by Lim primarily included patients with respiratory disease. This population includes hypercapnic patients, who are likely to have poorer agreement. However, regardless of the relatively low pooled Note: weights are from random effects analysis Overall (I 2 = 92.6%, P = 0.000)
Gennis et al. [12] Malatesha et al. [18] Gokel et al. [17] Raoufy et al. [13] Ma et al. [11] McCanny et al. [19] Gokel et al. [17] Eizadi-Mood et al. [20] Ak et al. [14] Rang et al. [7] Kelly et al. [10] Brandenburg and Dire [21] Shirani et al. [15] Razi and Moosavi [16] Shirani et al. [15] References 188 MD, the 95% LOA are very broad, indicating poor agreement, and therefore prohibit a direct replacement of arterial with venous PCO 2 .
Four studies examine the use of PvCO 2 as a screen for arterial hypercapnia. Kelly et al. [22] found that a PvCO 2 of 45 mmHg was a potential screening cutoff. Ibrahim et al. [23] went on to find that a PvCO 2 of less than 30 mmHg has 100% sensitivity and 100% negative predictive value (NPV) to rule out PaCO 2 greater than 45 mmHg, but a PvCO 2 of 45 mmHg was only 79% sensitive with a 90% NPV. Subsequently Kelly et al. [24] validated their previous results and showed that a PvCO 2 of less than 45 mmHg has a 100% NPV for PaCO 2 greater than 50 mmHg. In addition, all 43 cases of hypercapnia (PaCO 2 > 50 mmHg) in that study were detected by a screening cutoff of PvCO 2 less than 45 mmHg, which gave a sensitivity of 100%. McCanny et al. [19] investigated a sample of ED patients with a pre-existing diagnosis of COPD that were presenting with an acute exacerbation of COPD. They also demonstrated that a PvCO 2 of 45 mmHg was 100% sensitive for detecting arterial hypercapnia. This is a robust body of evidence that asserts that PvCO 2 can be used as a screen for hypercapnia, with a PvCO 2 less than 45 mmHg indicating that the PaCO 2 will not be greater than 50 mmHg.
Lactate
There are five published studies that compare venous lactate (VL) and arterial lactate (AL) in the ED. Two of these were excluded from this review because they examined the difference between arterial and central venous blood in a paediatric population [31] and in an ICU population [32] . Of those that investigated ED patients, two examined an undifferentiated ED sample [26, 27] and one ED trauma patients [25] .
Younger et al. [27] had a sample size of 48, 38% of which had a VL greater than 1.6 mmol/l (defined as abnormal) and 27% had an abnormal AL. The MD was 0.18 mmol/l with narrow 95% LOA. The proportion of their patients with haemodynamic compromise was not reported. Gallagher et al. [26] reported a sample size of 69. The MD was 0.22 mmol/l and the LOA were -1.3 to Note: weights are from random effects analysis Overall (I 2 = 96.8%, P = 0.000)
McCanny et al. [19] References Rang et al. [7] Shirani et al. [15] Gennis et al. [12] Ak et al. [14] Eizadi-Mood et al. [20] Kelly et al. [24] Ibrahim et al. [23] Razi and Moosavi [16] Kelly et al. [22] Malatesha et al. [18] Shirani et al. [15] Raoufy et al. [13] 1.7 mmol/l (VL -AL). The authors calculated that for a normal VL, the likelihood ratio for a raised AL was 0.1, indicating that a patient with a normal VL is highly likely to have a normal AL. However, of the 69 patients, only eight had an SBP of less than 100 mmHg and only five of those were considered to be shocked (tachycardic and hypotensive). Lavery et al. [25] investigated a trauma population and although agreement statistics are not reported, it is possible to calculate an MD of 0.32 mmol/l and a 95% LOA of -1.95 to 2.31 mmol/l. In this population 34% had an injury severity score greater than 13, indicating severe injury.
The pooled MD for these three reports is 0.25 mmol/l (95% CI 0. 15-0.35) . This is a low MD with narrow CIs; however, the 95% LOA for the MD of VL and AL are broad, ranging from -1.18 to 1.54 mmol/l narrowest and -1.95 to 2.31 mmol/l broadest. This latter study was of a population of major trauma patients and included a high proportion of critically ill patients. These data imply that the VL cannot be used as a proxy for AL in patients with abnormal lactate values. In addition, there are limited data as to the relationship between VL and AL in acidotic, hypotensive and hyperlactataemic patients. Therefore as the VL becomes abnormal, the true value of AL is less predictable from the VL and in these situations an arterial sample should be taken.
Clinical perspective
Bland and Altman suggested that if the MD between two values plus or minus two SDs is not clinically important, then the two values can be used interchangeably [2] . There is little evidence as to what may be acceptable to a clinician. Rang et al. [7] asked 45 board-certified emergency physicians from two academic centres to give their opinion of how different venous and arterial values of pH, PCO 2 and PO 2 could be before they would be uncomfortable to be used clinically. They found that the physicians' comfort zone was less than ±2 SD from the MD and therefore to include 95% of the differences Note: weights are from random effects analysis Overall (I 2 = 97.5%, P = 0.000)
Rang et al. [7] Eizadi-Mood et al. [20] Malatesha et al. [18] Kelly et al. [10] Raoufy et al. [13] Shirani et al. [15] Ak et al. [14] Shirani et al. [15] Gokel et al. [17] Gennis et al. [12] Gokel et al. [17] Razi A further source of bias could be variation in the electrodes used in different point-of-care machines. Moreover, unreported differences in sampling methods (e.g. whether a tourniquet was used) may decrease the reliability of generalizing the results.
Future developments
There is no evidence on the use of venous parameters, particularly PvCO 2 and VL in monitoring trends. In patients with type II respiratory failure, monitoring the response to therapy such as noninvasive ventilation using PvCO 2 offers clear clinical advantages. That the absolute value of PaCO 2 is not accurately reflected with PvCO 2 in hypercapnic patients may not necessarily be important, if the degree of hypercapnia and its change with therapy could be followed.
Poor lactate clearance has been shown to be a predictor of increased mortality [34] . The Surviving Sepsis Campaign guidelines on the management of severe sepsis do not specify whether the lactate taken is venous or arterial, indicating that a venous sample is adequate regardless of how deranged it is [35] . Future work should include the agreement between serial measurements of AL and VL.
Conclusion
Venous and arterial pH and bicarbonate agree reasonably at all values, but the agreement is highest at normal values. Arteriovenous agreement for PCO 2 is poor and PvCO 2 cannot be relied upon as an absolute representation of PaCO 2 . However, normal peripheral PvCO 2 has a good NPV for normal arterial PCO 2 , and a normal PvCO 2 can be used as a screen to exclude hypercapnic respiratory disease. There may be a poor agreement between AL and VL at Overall (I 2 = 0.0%, P = 0.491)
Lavery et al. [25] Gallagher et al. [26] Younger et al. [27] References Pooled mean differences for lactate with 95% confidence intervals (CIs). MD, mean difference.
The role of venous blood gas in the ED Bloom et al. 87 abnormal values; however, if the VL is normal, it is likely the arterial values of this parameter will also be normal.
